Welcome to ACC’s Prevention of Cardiovascular Disease Member Section!

Eugenia Gianos, MD, FACC

Eugenia Gianos, MD, FACC
Chair
@eugeniagianos

The ACC Prevention of Cardiovascular Disease Section was created in March 2014 and emerged from the original ACC Prevention Committee when it became clear that cardiovascular disease (CVD) prevention, both nationally and globally, was becoming a key priority of the college. Today, the prevention section is one of the most active and important groups.

The section's mission is to promote CVD prevention to our patients and cardiovascular team through advocacy, education, and research. The section serves as the primary home for ACC members interested in the broad area of CVD prevention. It includes members who are experts and leaders in all aspects of prevention, including cardiac imaging, cardiac rehabilitation, cardiometabolic disorders and diabetes, CVD risk assessment, digital strategy, disparities of care, hypertension, hyperlipidemia, nutrition and tobacco cessation.

Join the Prevention of Cardiovascular Disease Section — Today!

The Prevention of Cardiovascular Disease Member Section is only able to accomplish its mission through support from members. Members can join online by clicking here or by contacting ACC Member Care at (800) 253-4636, ext. 5603; or direct dial (202) 375-6000.

Already a member of the Prevention of Cardiovascular Disease Section? Click here to unlock the member exclusive section experience.

As our membership grows, so does the Prevention of Cardiovascular Disease Member Section's opportunities to impact College policies and provide additional member benefits.

Questions?

Questions? Contact ACC Member Care.

Section Announcements

Section News

Education

New Hypertriglyceridemia Online Course

June 22, 2026

Education

ACC’s new online course, Hypertriglyceridemia and CV Health: Recognizing Risks and Tackling Management, provides a focused overview of hypertriglyceridemia (HTG) and severe HTG, including key causes, associated risks like pancreatitis and cardiovascular disease, and essential diagnostic considerations. Gain insight into genetic conditions and practical management strategies, from lifestyle modifications to pharmacotherapy, helping clinicians tailor treatment based on individual patient risk and improve overall lipid outcomes. Join Michael Miller, MD, FACC, for Tips for Identifying Different Types of HTG and test your knowledge with two patient case quizzes – Severe HTG: Acute Risk Stratification and Immediate Management and Recurrent Extreme HTG: Diagnostic Workup and Suspecting Familial Chylomicronemia Syndrome. Plus, look for new activities coming soon! Learn more.

Education

New Online Course, Patient Tools Explore Role of UACR in CV Care

June 22, 2026

Education

Discover albuminuria’s clinical importance in cardiovascular care and how urine albumin-to-creatinine ratio (UACR) helps assess cardiovascular risk with ACC's new online course, Connecting the Kidneys and the Heart: Raising Awareness of the Central Role of UACR in CV Care. Learn how this simple, guideline-recommended test can uncover hidden kidney damage and significantly improve cardiovascular risk assessment. Explore a new clinician infographic and test your knowledge with patient case quizzes. Designed for the entire cardiovascular care team, the course highlights the clinical value of UACR screening and shares emerging evidence to help integrate it into routine practice and improve patient outcomes.

Plus, help patients understand the importance of UACR screening. A new CardioSmart patient infographic explains why UACR screening matters, what test results mean, and how lifestyle changes and appropriate treatments can help protect both heart and kidney health. The infographic is part of ACC’s efforts to implement the CKM Syndrome Guideline in daily practice. Visit the CardioSmart Kidneys and Your Heart Hub for more.

Announcements

Explore the Updated Lipid Manager App For Improved Lipid Management Support

June 16, 2026

Announcements

ACC’s newly updated Lipid Manager App provides clinical decision support tools to help clinicians manage a patient’s triglycerides and LDL-C – from therapy initiation through treatment calibration with the goal of lowering atherosclerotic cardiovascular disease (ASCVD) risk. Its update now incorporates the 2026 ACC/AHA Guideline on the Management of Dyslipidemia and utilizes the AHA PREVENT™-ASCVD risk estimator as part of the evaluation process, providing the latest in evaluation workflows and advice for lipid lowering therapy. Find out more and download the app.

View More Section News »

Resources